Dergi makalesi Açık Erişim
Erturk, Zeliha; Buber, Esra; Ozen, Haluk; Celikbicak, Omur; Salih, Bekir; Acan, N. Leyla
Objective: Immunotherapy with intravesical Bacillus Calmette-Guerin (BCG) application is a gold standard treatment for high risk non-muscle invasive bladder cancer (NMIBC), despite its local and systemic side effects. We aimed to develop less toxic and more powerful therapeutic agents for the treatment of bladder cancer than live strain.
| Dosya adı | Boyutu | |
|---|---|---|
|
10-4274-uob-905.pdf
md5:9ee20076cf9bc2d697f350d2c286b2c0 |
684.3 kB | İndir |
| Görüntülenme | 58 |
| İndirme | 45 |
| Veri hacmi | 30.8 MB |
| Tekil görüntülenme | 55 |
| Tekil indirme | 45 |